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O B J E C T I V E S The aim of this study was to assess the incidence, predictors, and outcome of plaque
prolapse (PP) after stent implantation in acute myocardial infarction.
B A C KG ROUND The imaging characteristics of PP in patients with acute myocardial infarction are
not well known.
METHOD S Intravascular ultrasound (IVUS) imaging was performed in 310 patients immediately
following stenting for their ﬁrst acute myocardial infarction. Multiple clinical, angiographic and IVUS
derived variables were compared among patients with and without intrastent PP.
R E S U L T S The PP was detected in 27% of the 310 lesions examined. Stent length was longer (31 
13 mm vs. 21  8 mm, p  0.001), and positive remodeling (48% vs. 32%, p  0.008), plaque rupture
(51% vs. 31%, p  0.001), and thrombus (40% vs. 21%, p  0.001) were signiﬁcantly more common in
PP lesions compared with non-PP lesions. The creatine kinase-myocardial band (CK-MB) was signiﬁcantly
greater after stenting in PP lesions compared with non-PP lesions (∆12.3 32.0 U/l vs.4.9 46.1
U/l, p  0.002). During a 1-month follow-up, the incidence of stent thrombosis was not signiﬁcantly
different between PP and non-PP lesions [2/85 (2.4%) vs. 2/225 (0.9%), p  0.308]. Multivariate analysis
showed that PP (odds ratio [OR]: 7.34, p  0.001), plaque rupture (OR: 1.95, p  0.023), and thrombus
(OR: 1.84, p  0.026) were independently associated with post-stenting CK-MB elevation, and stent
length (OR: 2.39, p  0.003), plaque rupture (OR: 1.96, p  0.015), and positive remodeling (OR: 1.72,
p  0.044) were independently associated with the development of PP.
CONC L U S I O N S PP occurs in one-fourth of infarct-related arteries after stent implantation. Lesion
characteristics such as plaque rupture and positive remodeling, together with longer stent predict PP.
Although long-term follow-up is pending, PP is associated with more myonecrosis after stenting in
patients with acute myocardial infarction. (J Am Coll Cardiol Img 2008;1:489–97) © 2008 by the
American College of Cardiology Foundation
From the Heart Center of Chonnam National University Hospital, Cardiovascular Research Institute, Chonnam National
University, Gwangju, Korea.Manuscript received February 11, 2008; revised manuscript received March 11, 2008, accepted April 9, 2008.
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490oronary angiography provides only simple,
planar projections of the three-dimensional
anatomy of the coronary lumen, and its
capacity for detecting intrastent plaque
rolapse (PP) is limited. As shown by previous
tudies (1,2), PP is not a rare phenomenon and has
een detected frequently by intravascular ultrasound
IVUS). Several factors relating to pre-intervention
See page 498
VUS, together with aggressive stenting proce-
ures, have been associated with PP (3,4). Some
tudies (5–7) have demonstrated that PP was asso-
iated with stent thrombosis. However, data on the
haracteristics of PP in patients with acute myocar-
ial infarction (AMI) are lacking. We used IVUS to
ssess the incidence, predictors, and outcome of PP
after stent implantation for infarct-related
arteries in AMI patients.
M E T H O D S
Patient population. From January 9, 2001,
to July 31, 2007, we identified a total of
310 patients with a first AMI. All under-
went pre-intervention IVUS within 24 h
of symptom onset, were stented success-
fully, and received post-intervention IVUS
imaging. Patients excluded were those
with prior MI, subacute or late stent
thrombosis, restenosis after stenting, and
coronary artery bypass graft failure. Pa-
tients studied with IVUS more than 24 h
after symptom onset and/or patients in
whom adequate IVUS images could not
e obtained were also excluded.
The presence of ST-segment elevation myocar-
ial infarction (STEMI) was identified by30 min
f continuous chest pain, a new ST-segment eleva-
ion 2 mm on at least 2 contiguous electrocardio-
raphic leads, and 3 times the normal level of
reatine kinase-myocardial band (CK-MB). The
resence of non-STEMI was diagnosed by chest
ain and a positive cardiac biochemical marker
ithout new ST-segment elevation. Infarct-related
rteries were identified using a combination of
lectrocardiographic findings, abnormalities of left
entricular wall motion on angiogram or echocar-
iogram, and coronary angiographic findings. All
10 infarct lesions were treated with stent implan-
ation: 138 with sirolimus-eluting stents (Cypher
und
iontent, Cordis, Johnson and Johnson, Miami Lakes, slorida), 49 with paclitaxel-eluting stents (Taxus
tent, Boston Scientific, Boston, Massachusetts), and
23 with bare-metal stents.
aboratory analysis. Venous blood samples were ob-
ained within 24 h of stenting. The blood samples
ere centrifuged, and serum was removed and
tored at70°C until the assay could be performed.
bsolute CK-MB levels were determined by radio-
mmunoassay (Dade Behring Inc., Miami, Florida).
ardiac-specific troponin I levels were measured
sing paramagnetic particles and a chemilumines-
ent immunoenzymatic assay (Beckman, Coulter
nc., Fullerton, California). The serum levels of
otal cholesterol, triglyceride, low-density lipopro-
ein cholesterol, and high-density lipoprotein cho-
esterol were measured using standard enzymatic
echniques.
ngiographic analysis. Coronary angiograms were
nalyzed with a validated quantitative coronary
ngiography system (Philips H5000 or Allura DCI
rogram, Philips Medical Systems, Eindhoven, the
etherlands). Using the outer diameter of the
ontrast-filled catheter as the calibration standard,
he minimal lumen diameter and reference diameter
ere measured in diastolic frames from orthogonal
rojections. Myocardial blush scores were catego-
ized into 4 densitometric grades based on a visual
ssessment of contrast opacification of the area
ontaining the infarct-related artery, as previously
escribed (8).
lectrocardiogram analysis. All patients underwent a
2-lead ECG at baseline and again 90 min after the
rocedure. The ST-segment elevation was manu-
lly measured 20 ms from the J-point, as previously
escribed (9). The ST-segment resolution was ex-
ressed as a percentage of the initial ST-segment
nd a value 70% was defined as indicative of
uccessful myocardial reperfusion 90 min after the
ndex procedure.
VUS imaging and analysis. All IVUS examinations
ere performed before and after stenting after
ntracoronary administration of 300-g nitroglyc-
rin using a commercially available IVUS system
Boston Scientific Corporation/SCIMed, Minne-
polis, Minnesota). The IVUS catheter was ad-
anced distal to the target lesion, and imaging was
erformed retrograde to the aorto-ostial junction at
n automatic pullback speed of 0.5 mm/s.
IVUS analysis was performed according to the
merican College of Cardiology Clinical expert
onsensus document on standards for acquisition,
easurement, and reporting of intravascular ultra-B B R E V I A T I O N S
N D A C R O N YM S
MI acute myocardial
nfarction
K-MB creatine kinase-
yocardial band
SA cross-sectional area
EM external elastic
embrane
VUS intravascular ultraso
&M plaque plus media
P plaque prolapse
TEMI ST-segment elevat
yocardial infarction
IMI Thrombolysis Inound studies (10). At pre-intervention, we mea-
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491ured the external elastic membrane (EEM) and
umen cross-sectional area (CSA). Plaque plus me-
ia (P&M) CSA was calculated as EEM CSA
inus lumen CSA, and plaque burden was calcu-
ated as P&M CSA divided by EEM CSA. The
esion was the site with the smallest lumen CSA; if
here were multiple image slices with the same
inimum lumen CSA, then the image slice with
he largest EEM and P&M was measured. Coro-
ary artery remodeling was assessed by comparing
he lesion site to the reference EEM CSA. Remod-
ling index was the lesion site EEM CSA divided
y the average of the proximal and distal reference
EM CSA. Positive remodeling was defined as a
emodeling index 1.05, intermediate remodeling
s a remodeling index between 0.95 and 1.05, and
egative remodeling as a remodeling index 0.95
11). Hypoechoic plaque was less bright compared
ith the reference adventitia. Hyperechoic, noncal-
ified plaque was as bright as or brighter than the
eference adventitia without acoustic shadowing.
alcium plaque was hyperechoic with shadowing.
calcified lesion contained90° of circumferential
esion calcium.
A ruptured plaque contained a cavity that com-
unicated with the lumen with an overlying resid-
al fibrous cap fragment. A fragmented and loosely
dherent plaque without a distinct cavity and with-
ut a fibrous cap fragment was not considered a
laque rupture. Rupture sites separated by a length
f artery containing smooth lumen contours with-
ut cavities were considered to represent different
laque ruptures (12,13). Plaque cavity was mea-
ured and extrapolated to the ruptured capsule area.
hrombus was an intraluminal mass having a lay-
red or lobulated appearance, evidence of blood
ow (microchannels) within the mass, and speck-
ing or scintillation (13,14). A lipid-pool-like image
as defined as a pooling of hypoechoic or echolu-
ent material covered with a hyperechoic layer.
At the time of post-intervention assessment, the
inimum stent CSA was measured. Percent stent
xpansion was calculated as the minimum stent
SA divided by the mean reference lumen CSA.
he PP was defined as tissue extrusion through the
tent strut, assessed post-intervention, and the vol-
me of PP was calculated by subtracting the lumen
olume from the stent volume.
tatistical analysis. The SPSS (Statistical Package
or Social Sciences) for Windows, version 15.0
Chicago, Illinois) was used for all analyses. Con-
inuous variables were presented as the mean valuestandard deviation; comparisons were conducted msing Student t test or, if the normality assumption
as violated, the nonparametric Wilcoxon test.
iscrete variables were presented as percentages
nd relative frequencies; comparisons were con-
ucted by chi-square statistics or Fisher exact test,
s appropriate. Multivariate logistic regression anal-
ses were performed to identify independent pre-
ictors of post-stenting CK-MB elevation and PP.
nivariate analyses were first conducted to identify
otential risk factors for post-stenting CK-MB
levation and PP. The likelihood ratio test was
sed, and the variables with a p value 0.2 were
ncluded in the multivariate model. Finally, a step-
own logistic regression was performed. The least
ignificant variable was dropped at each step until
nly covariates with a p value 0.05 remained. A p
alue 0.05 was considered statistically significant.
E S U L T S
atient characteristics. The baseline characteristics
re summarized in Table 1. There was a tendency
or PP to be observed more frequently in lesions
rom STEMI patients, compared with lesions from
atients with non-STEMI. Distal protection de-
ices were used more frequently in PP lesions than
n non-PP lesions. Total cholesterol levels were
ignificantly higher, and low-density lipoprotein
holesterol levels tended to be higher in patients
ith PP compared with patients without PP.
ngiographic and procedural results. Angiographic
ndings and procedural results are summarized in
able 2. Patients with PP tended to have culprit
esions in the right coronary artery, whereas those
ithout PP tended to have culprit lesions in the left
nterior descending artery. Angiographic lesion
ength was longer in patients with PP than in those
ithout PP. Stent length was longer, more stents
ere deployed, and inflation pressure was signifi-
antly higher in PP lesions compared with non-PP
esions. When we divided the lesions into 3 groups
ccording to the stent length (18 mm; 18 and
28 mm; and 28 mm), PP was most frequently
bserved in the group with stents 28 mm in
ength (Fig. 1).
VUS results. The IVUS findings are summarized in
able 3. Immediately after stenting, PP was detected
n 27% of lesions (maximum PP area: 0.7 0.5 mm2;
P volume: 2.3  1.7 mm3). There was a trend
oward increased PP when paclitaxel-eluting stents
ere used, compared with sirolimus-eluting or bare-
etal stents (paclitaxel-eluting stent, 19 of 49 [39%];
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492irolimus-eluting stent, 35 of 138 [25%]; bare-metal
tent, 31 of 123 [25%]; p  0.15).
There was a trend for the minimum lumen area
n the lesion site to be smaller in PP lesions
ompared with non-PP lesions. Lesion site P&M
SA, plaque burden, and remodeling index were
reater and calcium arc was smaller in PP lesions
ompared with non-PP lesions. The presence of
laque rupture, thrombus, lipid-pool-like images,
nd hypoechoic plaque were significantly more
ommon in PP lesions compared with non-PP
esions. Plaque cavity CSA was significantly greater
n PP lesions compared with non-PP lesions (PP:
.1  0.7 mm2; non-PP: 2.5  1.3 mm2; p 
.008).
When the incidence of PP was assessed in
elation to the presence/absence of plaque rupture,
P was observed more frequently in lesions with
laque rupture than in lesions without plaque rup-
ure (Fig. 2). When the lesions were divided into 3
roups according to their remodeling pattern (pos-
tive, intermediate, or negative), PP was most fre-
uently observed in the group showing positive
Table 1. Baseline Characteristics According to the Presence/Abs
PP (
Age (yrs) 65
Male gender 4
Clinical presentation
Non-STEMI 4
STEMI 4
Diabetes mellitus 3
Hypertension 6
Smoking 3
Family history of coronary artery disease 1
Previous percutaneous coronary intervention 3
Thrombolytic therapy 1
Glycoprotein IIb/IIIa inhibitors 2
Use of distal protection devices 1
Aspirin at admission 1
Statin at admission 1
Ejection fraction (%) 4
White blood cells (103/mm3) 8.
Hemoglobin (g/dl) 12.
Platelet count (103/mm3) 22
Creatinine clearance (ml/min) 6
Total cholesterol (mg/dl) 18
Triglyceride (mg/dl) 13
LDL cholesterol (mg/dl) 11
HDL cholesterol (mg/dl) 4
Data are presented as the n (%) of patients or mean  SD.
HDL  high-density lipoprotein; LDL  low-density lipoprotein; PP  plaqueemodeling (Fig. 3). The minimum stent CSA and Cercent stent expansion were significantly greater in
P lesions than in non-PP lesions.
ost-stenting elevation of cardiac enzyme and the
ncidence of stent thrombosis. Cardiac enzyme levels
ere significantly higher after stenting in patients
ith PP compared with patients without PP
CK-MB: PP 12.3  32.0 U/l and non-PP
4.9  46.1 U/l, p  0.002; cardiac-specific
roponin I: PP 16.3  55.5 ng/ml and non-PP
1.5  39.4 ng/ml, p  0.008). Multivariate
nalysis was performed to identify the indepen-
ent predictors of post-stenting CK-MB eleva-
ion. The following variables were tested (all with
 0.2 in univariate analysis): PP, creatinine
learance, Thrombolysis In Myocardial Infarc-
ion (TIMI) flow grade 0, stent length, inflation
ressure, IVUS plaque burden, plaque rupture,
hrombus, positive remodeling, and percent stent
xpansion. The PP (OR: 7.34; 95% CI: 3.55 to
5.19, p  0.001), plaque rupture (OR: 1.95;
5% CI: 1.10 to 3.46, p  0.023), and thrombus
OR: 1.84; 95% CI: 1.08 to 3.13, p  0.026) were
ach independently associated with post-stenting
e of PP
85) No PP (n  225) p Value
3 65 11 1.0
) 130 (58) 1.0
0.081
) 141 (63)
) 84 (37)
) 80 (36) 0.9
) 154 (68) 0.2
) 75 (33) 0.7
) 34 (15) 0.2
) 9 (8) 0.8
) 21 (9) 0.4
) 44 (20) 0.4
) 12 (5) 0.010
) 21 (9) 0.4
) 20 (9) 0.4
13 43 13 0.11
3.1 9.2 3.6 0.6
2.0 12.3 2.2 0.7
90 231 86 0.4
31 66 35 0.15
47 165 42 0.029
67 127 65 0.6
43 100 37 0.091
12 42 13 0.11
apse; STEMI  ST-segment elevation myocardial infarction.enc
n 
 1
9 (58
4 (52
1 (48
1 (37
4 (75
0 (35
8 (21
(10
1 (13
0 (24
2 (14
1 (13
0 (12
6
9
2
0
0
1
2
0
5K-MB elevation. At the time of the 1-month
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493linical follow-up, the incidence of stent throm-
osis was not significantly different between PP
nd non-PP lesions (PP: 2 of 85 [2.4%]; non-PP:
of 225 [0.9%]; p  0.308).
ost-stenting myocardial blush score and ST-segment
esolution in patients with STEMI. In 125 patients
ith STEMI, there was a trend for the rates of
ost-stenting myocardial blush score 2 (PP: 30 of
1 [73.2%]; non-PP: 73 of 84 [86.9%]; p  0.058),
nd for the complete ST-segment resolution to be
ower in patients with PP than in patients without
P (PP: 29 of 41 [70.7%]; non-PP: 71 of 84
84.5%]; p  0.070).
ndependent predictors of post-stenting PP. Multiva-
iate analysis was performed to identify indepen-
ent predictors of post-stenting PP. The following
ariables were tested (all with p  0.2 in univariate
nalysis): clinical presentation, distal protection de-
ice use, ejection fraction, creatinine clearance, total
holesterol, infarct-related artery, TIMI flow grade
, stent type, number of deployed stents, stent
ength, inflation pressure, quantitative coronary an-
Table 2. Coronary Angiographic Findings and Procedural Result
PP (n  85)
Infarct-related artery
Left main 0 (0)
LAD 36 (42)
LCX 14 (17)
RCA 35 (41)
Lesion location
Ostium 1 (1)
Proximal 31 (37)
Middle 46 (54)
Distal 7 (8)
Multivessel disease 41 (48)
Thrombus 14 (16)
Calcium 7 (8)
TIMI ﬂow grade 0 19 (22)
Stent type
Sirolimus-eluting stent 35 (41)
Paclitaxel-eluting stent 19 (22)
Bare-metal stent 31 (37)
No. of deployed stents (%) 1.5 0.6
Stent diameter (mm) 3.28 0.40
Stent length (mm) 31 13
Inﬂation pressure (mm Hg) 15.3 2.9
Reference diameter (mm) 3.32 0.85
Pre-MLD (mm) 0.63 0.32
Lesion length (mm) 23 12
Data are presented as the n (%) of patients or mean  SD.
LAD left anterior descending artery; LCX left circumﬂex artery; MLDmini
Infarction; other abbreviation as in Table 1.iography pre-minimal luminal diameter, IVUSPl
aq
ue
 P
ro
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e 
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)
≤18
0
15
30
45
60
15
(20/137)
p<0.001
50
(42/84)
Stent Length (mm)
26
(23/89)
>18, ≤28 >28
Figure 1. Incidence of PP in Relation to the Stent Length
Stent length was divided into 3 groups such as short stent length group
(less than 18 mm, n  137), intermediate stent length group (between 18
and 28 mm, n  89), and long stent length group (more than 28 mm, n 
84). Plaque prolapse (PP) was most frequently observed in the group with
the long stents (28 mm) compared with the groups with short- (18 mm)s According to the Presence/Absence of PP
No PP (n  225) p Value
0.024
5 (2)
131 (58)
28 (12)
61 (27)
0.8
3 (1)
90 (40)
109 (48)
23 (10)
112 (50) 0.8
22 (10) 0.10
23 (10) 0.6
30 (13) 0.052
0.15
103 (46)
30 (13)
92 (41)
1.1 0.3 0.001
3.24 0.46 0.7
21 8 0.001
14.1 2.6 0.001
3.27 0.72 0.5
0.68 0.51 0.18
15 8 0.001
mal lumen diameter RCA right coronary artery; TIMI Thrombolysis In Myocardialor intermediate-length (18 and 28 mm) stents.
m
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plaque rupture.
CSA  cross-sectional area; EEM  external elastic membrane; IVUS  intravascul
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494inimum lumen CSA, IVUS plaque burden,
laque rupture, thrombus, lipid-pool-like image,
ypoechoic plaque, calcium arc, positive remodel-
ng, and percent stent expansion. Stent length (OR:
.39; 95% CI: 1.17 to 3.89, p  0.003), plaque
upture (OR: 1.96; 95% CI: 1.14 to 3.37, p 
.015), and positive remodeling (OR: 1.72; 95%
I: 1.01 to 2.92, p  0.044) were each indepen-
ently associated with the development of PP.
I S C U S S I O N
he present study demonstrates that lesion charac-
eristics identified at pre-intervention IVUS,
amely plaque rupture and positive remodeling,
ogether with stent length predict PP. Furthermore,
P is associated with myonecrosis after stenting of
n infarct-related artery in patients with AMI.
The PP is characterized by an intraluminal tissue
xtrusion through the stent struts, and this is easily
etectable using IVUS. Several pre-intervention
VUS factors such as soft (rather than fibrous or
ce/Absence of PP
No PP (n  225) p Value
12.9 4.7 1.0
8.3 3.1 0.9
4.5 2.6 1.0
34 11 0.7
12.3 4.8 0.2
2.8 1.3 0.063
9.4 4.3 0.040
75.2 10.6 0.003
18 8 0.001
69 (31) 0.001
30 (13) 0.089
47 (21) 0.001
55 (24) 0.001
0.044
99 (44)
41 (18)
64 (28)
20 (9)
195 81 0.001
5.5 3.7 0.008
158 (70) 0.087
0.98 0.22 0.017
7.25 2.27 0.029
87 29 0.014
ar ultrasound; P&M  plaque plus media; other abbreviation as in Table 1.Pl
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0
10
20
30
40
p=0.001
Plaque
rupture (+)
38
(43/112)
21
(42/198)
Plaque
rupture (-)
Figure 2. Incidence of PP in Relation to the Presence or Absence of the
Plaque Rupture
A ruptured plaque contained a cavity that communicated with the lumen
with an overlying residual ﬁbrous cap fragment. A fragmented and loosely
adherent plaque without a distinct cavity and without a ﬁbrous cap frag-
ment was not considered a plaque rupture. The PP was observed more fre-
quently in lesions with plaque rupture compared with lesions withoutTable 3. Intravascular Ultrasound Findings According to the Presen
PP (n  85)
Reference
EEM CSA (mm2) 12.8 4.6
Lumen CSA (mm2) 8.3 3.0
P&M CSA (mm2) 4.6 2.6
Plaque burden (%) 35 11
Minimum lumen site
EEM CSA (mm2) 13.1 4.1
Lumen CSA (mm2) 2.5 1.5
P&M CSA (mm2) 10.6 4.2
Plaque burden (%) 79.5 13.0
IVUS lesion length (mm) 28 12
Plaque rupture 43 (51)
Multiple plaque rupture 18 (21)
Thrombus 34 (40)
Lipid-pool-like image 41 (48)
Plaque morphology
Hypoechoic 51 (60)
Hyperechoic, noncalciﬁed 11 (13)
Hyperechoic, calciﬁed 14 (17)
Mixed 8 (9)
Calcium arc (°) 114 76
Calcium length (mm) 3.6 2.7
Superﬁcial calcium 51 (60)
Remodeling index 1.04 0.21
Minimum stent CSA (mm2) 8.14 2.99
Stent expansion (%) 98 25
Data are presented as the n (%) of patients or mean  SD.alcified) plaque, smaller minimal lumen diameter,
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495nd larger plaque burden are known to be related to
P, and the risk of PP is known to be higher during
ggressive stenting procedures (3,4). Some studies
ave demonstrated that PP might contribute to the
evelopment of stent thrombosis (5–7).
The incidence of PP varies. Hong et al. (4)
eported that the incidence of minor PP in 407
ative coronary lesions was 23% in 384 patients
ho underwent IVUS-guided single bare-metal
tenting. Kim et al. (15) evaluated the incidence of
P according to the different drug-eluting stent
ypes (41 sirolimus-eluting stents and 42 paclitaxel-
luting stents) and different inflation pressures. In
he study by Kim et al. (15), the incidence of PP
as 41% (17 of 41 lesions) with the sirolimus-
luting stents versus 24% (10 of 41 lesions) with the
aclitaxel-eluting stents with an inflation pressure
f 14 atm, and 35% (14 of 40) in sirolimus-eluting
tents versus 17.8% (5 of 28) in paclitaxel-eluting
tents when an inflation pressure of 20 atm was
sed. Futamatsu et al. (16) reported that the inci-
ence of PP was 16% (9 of 56) after bare-metal
tent implantation, 16% (9 of 57) after sirolimus-
luting stent implantation, and 27% (15 of 55) after
aclitaxel-eluting stent implantation. In the present
tudy, PP was detected in 27% of patients and there
as a trend toward a higher incidence of PP when
aclitaxel-eluting stents were used compared with
irolimus-eluting or bare-metal stents.
The predictors of PP are not well understood in
atients with AMI. Hong et al. (4) reported that
he infarct-related artery and a small pre-
ntervention minimum lumen diameter were factors
ssociated with PP. Typical IVUS features observed
ollowing AMI include plaque rupture, thrombus
ormation, positive remodeling, and only either
potty or deep calcium within the minimum lumen
ite (17–24). Several studies (25,26) have reported
hat rupture of a vulnerable plaque and subsequent
hrombus formation is the most important mecha-
ism leading to an acute coronary syndrome. These
ulnerable plaques, especially those undergoing
laque rupture and positive remodeling (both of
hich were identified as independent predictors of
P in the present study), might facilitate tissue
xtrusion through the stent struts.
Multiple or long coronary stents are frequently
mplanted in long or tandem lesions. Kim et al. (15)
eported that implantation of long stents was asso-
iated with PP to a greater degree than was implan-
ation of shorter stents. In the present study, more
tents were deployed and stent length was greater in
atients with PP compared with patients without oP. This higher frequency of PP in patients who
nderwent long stent implantation might be caused
y uneven distribution of inflation pressure along
he length of the stent.
Elevation of the serum CK-MB fraction after
ercutaneous coronary intervention is associated
ith early and late mortality, even after successful
evascularization (27–31). The CK-MB release af-
er native coronary artery intervention is related to
he underlying plaque burden, disease severity, and
nstable plaque morphometry (positive remodeling
nd plaque rupture) (32,33). In addition to these
re-intervention IVUS findings, a more aggressive
tenting procedure appeared to be associated with
levation of CK-MB (27,33–35) and the develop-
ent of PP (4). In the present study, PP was
ndependently associated with post-stenting eleva-
ion of CK-MB. Although minor PP within stents
ight not be associated with long-term clinical
utcome (4), PP might be related to myonecrosis
fter stenting, especially for long lesions with un-
table plaque morphometry (plaque rupture and
ositive remodeling).
The potential risk of stent thrombosis associated
ith PP is another issue. The PP may act as a
rigger for thrombus accumulation in an environ-
ent that already has a high potential for throm-
ogenesis. Impaired arterial healing and stent
hrombosis have been associated with the prolapse
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Figure 3. Incidence of PP in Relation to the Remodeling Pattern
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496specially relevant in the setting of AMI, because
uch patients already have an increased risk for this
evastating event. However, in the present study,
he incidence of stent thrombosis was not signifi-
antly different between PP and non-PP lesions, as
ssessed during the 1-month clinical follow-up
although long-term clinical follow-up data were
ot collected).
tudy limitations. First, the present study is a retro-
pective single-center study, so it is subject to the
imitations inherent to this type of clinical investiga-
ion. Second, the number of PP was relatively small.
hus, some selection bias cannot be entirely excluded.
hird, it may be difficult to differentiate between an
rganized thrombus and a PP. It is possible that some
ases identified as having PP actually had thrombus
rolapse. Fourth, there may be enough differences
etween STEMI and non-STEMI to confound the
tatistical analysis (especially related to CK-MB ele-Hoorntje JC, et al. Randomized com- dromes and lesionshe measurement of a single CK-MB within 24 h
fter stent placement, rather than a methodical and
rotocol-driven sequence and timing of CK-MB
easurements. This may significantly compromise
he interpretation of the CK-MB data. Finally, long-
erm clinical follow-up was not available.
O N C L U S I O N S
he incidence of PP after stenting of infarct-related
rteries was 27%. Longer stent length and pre-
ntervention IVUS-detected plaque rupture and
ositive remodeling can predict PP, and PP is
ssociated with myonecrosis after stenting for
nfarct-related artery in patients with AMI.
eprint requests and correspondence: Dr. Myung Ho
eong, Director of Cardiovascular Research Institute, The
eart Center of Chonnam National University Hospital,
Hak-dong, Dong-gu, Gwangju 501–757, Korea. E-vation). Fifth, there are methodologic issues related to mail: myungho@chollian.net.1
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